Healthcare -
Biotechnology - NASDAQ - IL
$ 2.94
-2.65 %
$ 206 M
Market Cap
-6.84
P/E
Price Target
Average
138.10%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
35.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alpha Tau Medical Ltd.
Wall Street analysts predict an average 1-year price target for DRTS of $7 , with forecasts ranging from
a
low of
$7 to a high of $7 .
DRTS Lowest Price Target
Wall Street Target
7 USD
138.10%
DRTS Average Price Target
Wall Street Target
7 USD
138.10%
DRTS Highest Price Target
Wall Street Target
7 USD
138.10%
REVENUE FORECAST
Revenue Forecast Chart DRTS
EBIT FORECAST
EBIT Forecast Chart DRTS
NET INCOME FORECAST
Net Income Chart DRTS